Needle-Free Diabetes Management Market Research and Development, And the Demand for New Products and New Applications

The surging awareness on the safety issues with needles, growing aging population, and massive demand for needle-free treatment devices are driving the growth of the needle-free diabetes management market. In 2016, the market attained a size of $3,830.6 million, and it is predicted to generate revenue of more than $16,800.0 million by 2025. Needle-free diabetes management is a technique of monitoring, diagnosing, and treating a diabetic patient without the use of needles. Such devices are adopted for monitoring the blood glucose level and injecting insulin into diabetic patients.

On the basis of region, the needle-free diabetes management market is classified into Asia-Pacific, Europe, North America, and Rest of the World. Among these, during 2014–2016 (historical period), North America led the market in terms of revenue, and it is projected to continue leading it during 2017–2025, owing to the high prevalence of diabetes, technological advancements, and positive government regulations. In North America, due to the surging geriatric population and prevalence of obesity, diabetes has become one of the major public health issues.

With advancements in the needle-free injection technology, the treatment of diabetes has become more effective and convenient. There are different types of treatment devices, such as insulin patches, pumps, and inhalers, available in the market. The surging sale of such devices is predicted to contribute to the growth of the needle-free diabetes management market during the forecast period. Owing to their low immunity level, longer recovery time, and susceptibility to chronic diseases, including diabetes, the elderly need extensive care. According to ADA, around 25.0% of the population aged 60 years or above has diabetes in the U.S.

Furthermore, needle stick injuries during insulin administration can lead to blood-borne pathogen transmission, which can further cause fear, anxiety, and emotional distress in patients and healthcare workers. With the use of needle-free diabetes management, the risk of needle stick injuries can be eliminated. According to the World Health Organization, each year contaminated injections cause around 1.3 million early deaths. As needle-free diabetes management helps in reducing the number of deaths, it is highly preferred by patients as well as healthcare providers, thereby leading to the needle-free diabetes management market growth.

Hence, the surging aging population and safety associated with needle-free diabetes management are projected to contribute to the progress of the market during the forecast period.

Read More….